Letrozole
Femara (letrozole) is a small molecule pharmaceutical. Letrozole was first approved as Femara on 1997-07-25. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.
| Trade Name | Femara |
|---|---|
| Common Name | Letrozole |
| Indication | breast neoplasms |
| Drug Class | Aromatase inhibitors (imidazole/triazole derivatives) |
